Sphera Funds Management Ltd. Lava Therapeutics Nv Transaction History
Sphera Funds Management Ltd.
- $545 Million
- Q3 2024
A detailed history of Sphera Funds Management Ltd. transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 146,457 shares of LVTX stock, worth $152,315. This represents 0.04% of its overall portfolio holdings.
Number of Shares
146,457
Previous 367,582
60.16%
Holding current value
$152,315
Previous $661,000
63.24%
% of portfolio
0.04%
Previous 0.1%
Shares
6 transactions
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $26.8M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...